Entrust Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Entrust Financial's BMY Position: Q2 2026 in Review
Entrust Financial increased its Bristol-Myers Squibb (BMY) stake by 0.69% in Q2 2026, buying an estimated $345 and bringing the position to 870 shares worth $50.1K. The position accounts for 0.03% of the portfolio, ranked #146.
Entrust Financial first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $52.4K in Q1 2026. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Entrust Financial held 870 shares of Bristol-Myers Squibb worth $50.1K as of Q2 2026.
- Entrust Financial bought 6 Bristol-Myers Squibb shares in Q2 2026, an estimated $345.
- Bristol-Myers Squibb made up 0.03% of Entrust Financial's portfolio in Q2 2026, its #146 holding.
- Entrust Financial first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- Entrust Financial's Bristol-Myers Squibb position peaked at $52.4K in Q1 2026.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Entrust Financial's 13F filing for Q2 2026, filed 20 Jul 2026.